Neurelis, Inc. is a neuroscience-based company dedicated to developing innovative treatments for people living with neurological conditions. With a focus on enhancing therapeutic benefits and addressing unmet needs in care, Neurelis is committed to empowering individuals to define their own journey. The company boasts a range of proprietary non-invasive drug delivery technologies, including Intravail, ProTek, and Hydrogel, which enhance drug development and clinical performance. Neurelis's pipeline includes several FDA-approved treatments and investigational product candidates at various stages of development. Neurelis is also involved in community activities and offers saving and support programs to ensure accessibility of their therapies.
November 9
Lead HCP marketing strategies for VALTOCO at Neurelis.